Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.
about
Recombinant tissue plasminogen activators (rtPA): a review.In Vitro Capture of Small Ferrous Particles with a Magnetic Filtration Device Designed for Intravascular Use with Intraarterial Chemotherapy: Proof-of-Concept StudySynthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot DissolutionVascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.Translational initiatives in thrombolytic therapy.Leach-proof magnetic thrombolytic nanoparticles and coatings of enhanced activityTissue Plasminogen Activator Binding to Superparamagnetic Iron Oxide Nanoparticle-Covalent Versus Adsorptive Approach.Chitosan-assisted immobilization of serratiopeptidase on magnetic nanoparticles, characterization and its target delivery.Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy.In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.Polyacrylic acid-coated and non-coated iron oxide nanoparticles induce cytokine activation in human blood cells through TAK1, p38 MAPK and JNK pro-inflammatory pathways.Spectrophotometric analysis of thrombolytic activity: SATA assay.Magnetically controlled release of recombinant tissue plasminogen activator from chitosan nanocomposites for targeted thrombolysisDelivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage
P2860
Q34462146-976022CC-972F-4728-A4CE-99EA29511AF8Q36624437-230BC2B9-1540-4442-AFC1-42976CBE2095Q38637802-146EAD64-04AC-41FE-9552-17CE4DBFB213Q39031301-7B999C99-5856-49A3-915F-340675264B99Q39100187-3CB39B10-24B5-42F6-AE30-55770E70D486Q41856837-2147C075-E2A0-460A-BB5E-194319B5E743Q42109895-71A76066-F5CC-439C-AC1F-06AE72BDEF38Q44320150-BE7B687D-EE49-4F65-B7C3-065623229263Q47741822-A7E892F6-B2AE-4A89-BEB4-1810C8B39BB7Q47931181-84BD7D33-2D45-4948-9292-68DC476DB121Q48159250-F1B6F0F8-3370-4F69-B7DB-51F02E95B143Q51144453-505507FC-0B9B-4F32-AF06-0744132F0281Q53589220-3990ACBA-6219-4149-BEE0-903705ACFB58Q55072019-01C37763-3068-41E9-BDA6-CA9A2E3EF7C6Q55334341-3663CCD6-5B1E-4533-A422-19C6E0B40A0AQ57377087-B4E632FE-188F-485A-99E0-50DAD09295AFQ57377620-304C2A18-6F95-4928-997D-18AFD97976DD
P2860
Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeted delivery of tissue pl ...... -coated magnetic nanoparticle.
@ast
Targeted delivery of tissue pl ...... -coated magnetic nanoparticle.
@en
type
label
Targeted delivery of tissue pl ...... -coated magnetic nanoparticle.
@ast
Targeted delivery of tissue pl ...... -coated magnetic nanoparticle.
@en
prefLabel
Targeted delivery of tissue pl ...... -coated magnetic nanoparticle.
@ast
Targeted delivery of tissue pl ...... -coated magnetic nanoparticle.
@en
P2093
P2860
P356
P1476
Targeted delivery of tissue pl ...... a-coated magnetic nanoparticle
@en
P2093
Pei-Ching Yang
P2860
P304
P356
10.2147/IJN.S36197
P407
P577
2012-09-27T00:00:00Z